Will Fluor's Q2 2026 ending cash + marketable securities drop below $1.5B?
Current Prediction
Why This Question Matters
Stress Scanner identified mid-2026 as the weakest pro-forma liquidity point. Pro-forma post-NuScale cash entered Q1 2026 at ~$2.7B. Q2 deductions: $400M+ NuScale tax bill, ~$300M+ quarterly buyback, Urban legacy project funding, declining JV distributions. A drop below $1.5B would signal the cash bridge tighter than guided and would pressure FUNDING_FRAGILITY toward STRETCHED ahead of second-half awards.
Prediction Distribution
Individual Predictions(9 runs)
Base case math: $2.7B starting - $400M tax - $400M buyback (Q1+Q2) - $110M legacy project funding - $50M JV distribution shortfall + $150M H1 OCF = ~$1.89B Q2 ending cash. Threshold $1.5B requires another $400M of unforeseen pressure (e.g., working capital build, additional buyback acceleration, Mexico project cash injection). Plausible but not base case. Stress Scanner specifically classified the cash position as RESILIENT not STRETCHED.
Higher because the buyback pace in Jan-Feb ($400M for 2 months = $200M/month) implies Q1+Q2 buyback of $1.2B if sustained — that compresses the bridge. With $400M tax, $1.2B buyback (Q1+Q2), $110M legacy, $50M JV decline, less $150M OCF = $0.99B Q2 ending. If pace moderates to $300M/quarter from Q2, ending cash is ~$1.5B — right at threshold. The probability hinges on whether management slows the pace mid-year.
Lower probability. Stork divestiture and CFHI yard sale (>$120M) likely close in H1 2026 — adding ~$200M capital. Management likely paces buyback to maintain $1.5-2B liquidity floor — they have visibility into cash flow patterns and would not exhaust mid-year. NuScale tax bill timing could be later in Q2 (June) leaving Q2 ending cash less depressed. Working capital often releases in EPC businesses with progress billings on second-half awards arriving.
Around 30%. Base case math suggests Q2 ending cash $1.7-2.0B, above threshold. But variance is high — if buyback pace sustains, working capital builds, or Mexico project requires cash, threshold is reachable. Stress Scanner classification (RESILIENT) suggests management buffers comfortably above $1.5B.
Slightly higher. The Jan-Feb buyback pace at $200M/month (vs $300M/quarter implied by $1.4B annual plan) suggests aggressive front-loading. If Q1+Q2 buyback is $700-900M and tax is $400M+ in Q2, working capital builds during H1, the ending Q2 cash could be at or below $1.5B. Stress Scanner risk language explicitly flagged 'pressure cash position to under $1B mid-year' as a downside scenario.
Around 30%. The cash bridge has multiple offsets (Stork, CFHI, working capital release, Q3-Q4 award progress billings) and management discretion to pace buyback. Probability of breaching $1.5B at Q2 end specifically is moderate-low.
Around 30%. Base case Q2 ending ~$1.8-2.0B. Threshold reachable if Mexico stress + buyback pace + working capital all adverse.
Lean somewhat higher. Aggressive Jan-Feb buyback pace pressures bridge. Tax bill Q2 timing matters.
Slightly lower. Stork + CFHI proceeds provide capital. Management paces conservatively.
Resolution Criteria
Resolves YES if Fluor's reported Q2 2026 ending cash + marketable securities is below $1.5B per Q2 2026 10-Q. Resolves NO if at or above $1.5B.
Resolution Source
Fluor Q2 2026 10-Q filing or earnings release
Source Trigger
Q2 2026 cash position — $400M+ NuScale tax bill + buyback cadence + working capital pressure converge mid-year; weakest pro forma liquidity point. Pro-forma cash post-final-NuScale ~$2.7B at Q1 2026 entry.
Full multi-lens equity analysis